Cello Health acquires Innovative Science Solutions

Cello Health has acquired ISS, a scientific consulting firm specialising in strategic counsel and regulatory support for the healthcare industry in the US, including assisting with FDA advisory committee meetings, and supporting healthcare related clients with data provision in mounting legal defence around patent and intellectual property issues.
Co-Founder of Innovative Science Solutions, Steven Weisman, said: “Cello Health’s core capabilities and market reach greatly enhance the value we can offer our clients in addressing their scientific needs that span the health care product lifecycle. We are extremely excited to be joining Cello Health.”
CEO of Cello Health US, Julia Ralston, said: “We are excited about the acquisition of ISS at this stage in our US evolution. ISS has built a strong reputation for provision of its scientific consulting services. Adding this technical offer will benefit our clients, particularly by tackling their biggest challenges in navigating critical scientific, commercial, and regulatory pathways to successful commercialisation.”